Literature DB >> 31317054

MRI-based method for lower urinary tract dysfunction in adult male mice.

Dalton T McLean1,2, David R Rutkowski3,4, Teresa Liu1,5, Diego Hernando4,5,6, William A Ricke1,5, Alejandro Roldán-Alzate3,4,5,7.   

Abstract

Benign prostatic hyperplasia (BPH) develops in the majority of men as they age. As a result, lower urinary tract symptoms (LUTS) often develop, which significantly decrease quality of life. One model of studying BPH/LUTS in mice is to use a hormone-induced model of lower urinary tract dysfunction (LUTD), but current methods for studying endpoints require multiple analysis techniques that contribute to an overall lengthy process. However, developments in magnetic resonance imaging (MRI) have opened the door for more accurate and time efficient methods. The purpose of this study was to demonstrate the capabilities of MRI for the analysis of LUTD in mice. To do this, whole and partial urogenital tracts were extracted from mice and imaged on a 9.4 Tesla MRI system. Additionally, a device was designed and fabricated to aid in the imaging of up to 100 mouse urogenital tracts in a single imaging session. Images were processed for both qualitative representation of MRI resolution capabilities and quantitative measurements of urogenital tract components. Even the smallest anatomical structures of the urogenital tracts were resolved and quantified, including the ureters, urethra, ductus deferens, and fine nodules and textures on the seminal vesicles, bladder, and prostatic lobes. The visual representations and urogenital component quantifications demonstrated in this study may be of value in lesion detection, diagnosis, and LUTS symptom progression tracking.

Entities:  

Keywords:  BPH; MRI; lower urinary tract dysfunction; urogenital

Year:  2019        PMID: 31317054      PMCID: PMC6627546     

Source DB:  PubMed          Journal:  Am J Clin Exp Urol        ISSN: 2330-1910


  13 in total

Review 1.  Male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH).

Authors:  Claus G Roehrborn
Journal:  Med Clin North Am       Date:  2011-01       Impact factor: 5.456

Review 2.  Androgens and estrogens in benign prostatic hyperplasia: past, present and future.

Authors:  Tristan M Nicholson; William A Ricke
Journal:  Differentiation       Date:  2011-05-26       Impact factor: 3.880

Review 3.  Review of Prostate Anatomy and Embryology and the Etiology of Benign Prostatic Hyperplasia.

Authors:  LaTayia Aaron; Omar E Franco; Simon W Hayward
Journal:  Urol Clin North Am       Date:  2016-08       Impact factor: 2.241

4.  Benign prostatic hyperplasia: an overview.

Authors:  Claus G Roehrborn
Journal:  Rev Urol       Date:  2005

Review 5.  Can we identify men who will have complications from benign prostatic obstruction (BPO)? ICI-RS 2011.

Authors:  Matthias Oelke; Ruth Kirschner-Hermanns; Nikesh Thiruchelvam; John Heesakkers
Journal:  Neurourol Urodyn       Date:  2012-03-13       Impact factor: 2.696

6.  Testosterone and 17β-estradiol induce glandular prostatic growth, bladder outlet obstruction, and voiding dysfunction in male mice.

Authors:  Tristan M Nicholson; Emily A Ricke; Paul C Marker; Joseph M Miano; Robert D Mayer; Barry G Timms; Frederick S vom Saal; Ronald W Wood; William A Ricke
Journal:  Endocrinology       Date:  2012-09-04       Impact factor: 4.736

7.  Diagnosis and management of benign prostatic hyperplasia in primary care.

Authors:  Simon Tanguay; Murray Awde; Gerald Brock; Richard Casey; Joseph Kozak; Jay Lee; J Curtis Nickel; Fred Saad
Journal:  Can Urol Assoc J       Date:  2009-06       Impact factor: 1.862

8.  Characterization of fibrillar collagens and extracellular matrix of glandular benign prostatic hyperplasia nodules.

Authors:  Tyler M Bauman; Tristan M Nicholson; Lisa L Abler; Kevin W Eliceiri; Wei Huang; Chad M Vezina; William A Ricke
Journal:  PLoS One       Date:  2014-10-02       Impact factor: 3.240

9.  Importance of prostate volume and urinary flow rate in prediction of bladder outlet obstruction in men with symptomatic benign prostatic hyperplasia.

Authors:  Darius Trumbeckas; Daimantas Milonas; Mindaugas Jievaltas; Aivaras Jonas Matjosaitis; Marius Kincius; Aivaras Grybas; Vytis Kopustinskas
Journal:  Cent European J Urol       Date:  2011-06-02

10.  Assessment of BPH/BOO.

Authors:  Altaf Mangera; Nadir I Osman; Christopher R Chapple
Journal:  Indian J Urol       Date:  2014-04
View more
  1 in total

1.  Bisphenol-A analogs induce lower urinary tract dysfunction in male mice.

Authors:  J L Nguyen; E A Ricke; T T Liu; R Gerona; L MacGillivray; Z Wang; B G Timms; D E Bjorling; F S Vom Saal; W A Ricke
Journal:  Biochem Pharmacol       Date:  2022-01-01       Impact factor: 6.100

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.